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Abstract
Background: Lemierre's syndrome presents a classic clinical picture, the pathophysiology of
which remains obscure. Attempts have been made to trace genetic predispositions that modify the
host detection of pathogen or the resultant systemic reaction.
Case presentation: A 17-year old female, with no previous medical history, was admitted to the
intensive care unit for septic shock, acute respiratory distress syndrome and Lemierre's syndrome.
Her DNA was assayed for single nucleotide polymorphisms previously incriminated in the
detection of the pathogen, the inflammatory response and the coagulation cascade. We observed
functional variations in her Toll like 5 receptor (TLR 5) gene and two coagulation variations (Tissue
Factor (TF) 603 and Plasminogen-Activator-Inhibitor-1 (PAI-1) 4G-4G homozygosity) associated
with thrombotic events.
Conclusion: The innate immune response and the prothrombogenic mutations could explain, at
least in part, the symptoms of Lemierre's syndrome. Genomic study of several patients with
Lemierre's syndrome may reveal its pathophysiology.
Background
Lemierre's syndrome presents a classic [1] but exceptional
clinical picture (0.8 per million people per year) [2], the
physiopathology of which remains obscure. Over the last
few years, there has been a noticeable increase in efforts to
identify genetic predispositions that modify the detection
of the pathogen by the host or the resultant systemic reac-
tion, efforts that may enhance our understanding of this
syndrome. This article describes a young woman with
Lemierre's syndrome who was found to carry several
genetic polymorphisms: a single nucleotide polymor-
phism (SNP) in the TLR 5, and SNPs on the gene promot-
ers coding for TF and PAI-1.
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Case presentation
A 17-year old female with no previous medical history
was admitted to the emergency room of a general hospital
due to a deterioration of her general condition, with fever,
dyspnea and a paroxysmal severe cough. Two weeks pre-
viously, she had presented with an acute pharyngitis,
which was treated with amoxicillin for 8 days. At admis-
sion, she presented with persistent lateral cervical pain,
hyperleukocytosis (leukocyte count of 13,300/m-3,
including 90% neutrophils) and a CRP at 450 mg/L, com-
bined with an X-ray shadow on the bottom left lung. This
led to a diagnosis of community acquired pneumonia.
Blood samples were collected for culture and the patient
benefited from treatment with amoxicillin/clavulanic acid
and erythromycin.
After 48 hours in hospital, the blood cultures were posi-
tive for anaerobic Gram negative bacilli. Her antibiotic
therapy was modified, to a combination of cefotaxime,
gentamicin and metronizadole. Following the appearance
of pain in the two hypochondria, a thoraco-abdominal CT
scan was performed, which revealed a voluminous build-
up of air and fluid in the left thorax (Fig 1A) and a heter-
ogeneous hepato-splenomegaly. Within a few hours, the
patient presented with a body temperature of 39°7, respi-
ratory failure with hypotension and awareness disorders,
requiring the use of mechanical ventilation and vascular
filling with crystalloids followed by the administration of
norepinephrine (1 µg/kg/min). She was diagnosed with
Lemierre's syndrome and transferred to the intensive care
unit of a university hospital center.
At admission to the intensive care unit, the patient pre-
sented with severe ARDS, with a PaO2/FiO2 ratio at 65
mmHg, PEEP14, bilateral alveolo-interstitial syndrome,
left pyopneumothorax on chest x-ray (Fig 1B) and septic
shock. Biologically, her CRP was 475 mg/L and her procal-
citonine was 92 mg/L. A left thoracic drain was installed,
which removed 350 ml of the purulent liquid. Mechanical
ventilation was implemented according to the recommen-
dations of the National Institutes of Health. Her antibiotic
regimen was modified to a combination of imipenem/cil-
astatin (3000 mg/day) and metronidazole (1500 mg/
day). An ACTH test was performed, which showed 840
nmol/Lat baseline and 895 nmol/L 1 hour after injection,
and she was started on treatment with 300 mg/day hydro-
cortisone.
Four days later, a second set of thoracic, cerebral and
abdominal CT scans was performed. In addition to the
abscess of thelingula and the drained pyopneumothorax,
these scans revealed a large number of small abscesses of
the upper and median lobes of the right lung (Fig 1C), a
stable appearance of the hepato-splenomegaly and a par-
tial thrombosis of the left internal jugular vein, without
any appearance of stroke.
The anaerobic Gram negative bacillus was identified as a
Fusobacterium necrophorum sensitive to penicillin, and she
was treated with penicillin G for 15 days. The patient
improved, becoming apyretic and with normal blood
pressure. Withdrawal of ventilation was started and the
patient was weaned from the the respiratory asssitance
after 3 days. She was discharged from the intensive care
unit 12 days after admission.
Her DNA was assayed for SNPs previously incriminated in
the detection of the pathogen, the inflammatory response
and the coagulation cascade (Table 1). We observed func-
tional variations in her TLR 5 gene and two coagulation
variations (heterozygous TF603 and PAI-1 4G-4G
homozygosity) associated with thrombotic events.
Discussion
Lemierre's syndrome is frequently due to infection with a
strictly anaerobic Gram negative bacillus, Fusobacterium
necrophorum, a saprophyte of the oropharynx, digestive
tract and genital pathways. Lemierre's syndrome, which
mainly affects young patients without any previous medi-
cal history, consists of a combination of fever, shivering,
Initial thoracic CT-scan (A) and chest X-ray (B), thoracic CT-scan after chest tube and under mechanical ventilation (C)Figure 1
Initial thoracic CT-scan (A) and chest X-ray (B), thoracic CT-scan after chest tube and under mechanical ventilation (C).
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deterioration of the general condition, and pain and/or
cervical tumefaction along the sterno-cleido-mastoid
muscle, resulting from a suppurative thrombophlebitis of
the tonsillar and peri-tonsillar veins that can extend to the
internal jugular vein. This rare syndrome usually occurs
following a banal pharyngitis. The appearance of pulmo-
nary symptomatology (cough, dyspnea, thoracic pain)
and/or abdominal symptomatology (hepato and/or
spleno-megaly, hepatalgia, cholestasis and/or biological
cytolysis) suggesting septic metastases, points to Lem-
ierre's syndrome and justifies the implementation of a
suitable antibiotic regimen. Other septic phenomena,
such as arthritis, mediastinitis, meningitis and/or endo-
carditis, are found more rarely.
The physiopathology of Lemierre's syndrome remains
controversial. Fusobacterium necrophorum [3] is a commen-
sal of the normal flora of the human oropharynx, diges-
tive tract, genital and urinary pathways and normally does
not invade those mucosae. It is not known why Fusobacte-
rium necrophorum becomes pathogenic in certain individ-
uals, although a lowering of local pharyngeal defenses
following a viral or bacterial infection may encourage this
invasion by creating an anaerobic micro environment [4].
Another explanation is based on the capacity of these bac-
teria to secrete hemolysins, hemagglutinins and leukoci-
dins, resulting in the formation of micro-abscesses by
fibrin and platelet aggregation.
The recent discovery of anti-infection defense mecha-
nisms, in particular Toll like receptors, and the finding
that these receptors have functional variations open up
new avenues in the pathophysiology of the Lemierre's
syndrome, as illustrated in this clinical case.
The innate immune response to Fusobacterium necro-
phorum is complex and involves both tissue immunity
(cathelicidins and defensins) and cellular immunity (TLR
receptors). Although Fusobacterium necrophorum is not a
flagellate bacterium, it is capable of synthesizing Pilin [5].
Pilin and type IV pili (monomer), may be one of the TLR5
triggers. The TLR5-F616L and TLR5-R392 mutations,
which are associated with infections by flagellate bacteria,
such as Legionella pneumophila [6], may also be associated
with Fusobacterium necrophorum infections. To date, there
is no scientific proof with this assertion.
A second facet of the symptomatology of Lemierre's syn-
drome is the presence of hypercoagulability, resulting in
thrombophilia. A procoagulating mutation of pro-
thrombin was recently associated with this syndrome [7].
Interestingly, we observed a combination of one pro-
thrombogenic and one anti-fibrinolytic variations in our
patient. The last one was the 4G-4G homozygous gento-
type of the PAI-1 gene which encodes for a primary anti-
fibrinolytic molecule. This gentotype is responsible for an
increase in plasma concentrations of PAI-1. Moreover,
this mutation alone [8] or in combination with other pro-
thrombotic genetic anomalies [9,10] is a risk factor for
myocardial infarction and venous thrombo-embolic phe-
nomena. The pathophysiology of sepsis is due to imbal-
ances in the coagulation and fibrinolysis systems, and any
factor that accentuates these imbalances can influence the
host response. Patients suffering from meningococcemia
and whose close relatives were carriers of the 4G-4G gen-
otype were found to be 6 times more likely to develop sep-
tic shock rather than meningitis [11]. Moreover, this
genotype was also found to be associated for an increase
in the mortality of patients suffering from multiple inju-
Table 1: Genotype findings at all loci tested. Functional variations were observed in the TLR 5 gene, the flagellin receptor, TLR5-
F616L, a heterozygous mutation TLR5-R392 and two coagulation variations resulting in thrombotic events (HT TF603 and PAI-1 4G-
4G homozygous). Genes encoding proteins involved in inflammation genes were normal.
Ref WT/WT WT/M M/M WT/WT WT/M M/M
TLR2 R753Q rs5743708 X IL 10-1082 rs1800872 X
TLR5-R392 rs5744168 X TNF b1/b2 rs2229094 X
TLR5-N592S rs2072494 X TNF 238 rs361525 X
TLR5-F616L rs5744174 X TNF 308 rs1800629 X
TLR4 D299G rs4986790 X TNF 376 rs1800750 X
Fc-GrIIα rs1801274 X PAI-1 rs1799768 X
CD 14 rs2569190 X Fibrinogen rs6050 X
SPD 11 rs721917 X TF p603 [14] X
SPD 160 rs2243639 X EPCR rs867186 X
MIF rs755622 X Factor II rs1799963 X
IL 6 rs1800795 X Factor V Rs6025 X
IL 10-592 rs1800872 X Factor VII Rs6046 X
Abreviations : Toll like receptor (TLR); Fc receptor for IgG (Fc-gamma RII); macrophage migration inhibitory factor (MIF); Endothelial protein C 
receptor (EPCR); Tissue factor (TF); Tumor Necrosis Factor (TNF); Surfactant Protein D(SPD); WT: Wild type concerns the frequent allele; M: 
mutation concerns the rare allele. Ref: reference number for the studied SNP.
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ries [12] and meningococcemia [13]. This SNP can there-
fore partly explain the physiopathology of Lemierre's
syndrome, as well as the severity of the clinical picture in
our patient. Similarly, the variation in tissue factor pro-
moter results in a spontaneous and induced overexpres-
sion of this trigger of coagulation during sepsis. Of course
we have assayed a selection of previously reported SNPs,
but many other potentially important reported candidate
SNPs have not been examined.
Conclusion
To our knowledge, this article is the first to identify SNPs
in a patient suffering from Lemierre's syndrome. The
innate immune response and the prothrombogenic muta-
tions observed in this patient could explain, at least in
part, the symptoms of Lemierre's syndrome. Genomic
study of several patients with Lemierre's syndrome may
help to reveal its complex pathophysiology.
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